DarioHealth Reports Results For Second Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
DarioHealth (DRIO) Reports In-Line Q2 EPS, Revenues Miss
August 13, 2019 6:23 AM EDTDarioHealth (NASDAQ: DRIO) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $1.65 million versus the consensus estimate of $2.45 million.
Q2 2019 Revenue of $1.65 million, a 20% decline from Q2 2018Record 1H 2019 Revenue of $3.89 million, a 2% increase over 1H 2018Expense shift from D2C to B2B, resulting in a short-term decline in Revenue and an expectation of significant reductions to Net loss in 2H 2019 Significantly advanced key 2019 initiative to expand growth strategy solely from the direct-to-consumer (D2C) channel to include the more scalable,... More